| Literature DB >> 27904275 |
Jisook Yoo1, Mingyul Jo1, Min-Soo Kim1, Kwang-Hyun Choi1, Hyang-Joon Park1, Mihn-Sook Jue1.
Abstract
Kaposi's sarcoma is a multifocal proliferative vascular tumor involving the skin and other organ and psoriasis is a chronic cutaneous disease with papules and plaques with white scale. Development of Kaposi's sarcoma in psoriasis patients has been reported rarely. A 71-year-old man presented with multiple brownish to violaceous plaques on both feet and arms which were found 4 months ago. The biopsy confirmed Kaposi's sarcoma. The patient was diagnosed with psoriasis vulgaris 10 years ago and Kaposi's sarcoma lesions developed between psoriatic plaques. We herein report a rare case of simultaneous occurrence of Kaposi's sarcoma and psoriasis vulgaris which need quite different treatment.Entities:
Keywords: Kaposi's sarcoma; Psoriasis
Year: 2016 PMID: 27904275 PMCID: PMC5125957 DOI: 10.5021/ad.2016.28.6.749
Source DB: PubMed Journal: Ann Dermatol ISSN: 1013-9087 Impact factor: 1.444
Fig. 1(A, B) Multiple red-brown papules and violaceous plaques on both legs and feet.
Fig. 2(A) A few angiomatous papules between psoriatic plaques on the elbow. (B) Violaceous lesions suspicious of Kaposi's sarcoma were hidden between extensive psoriatic lesions in clinical photos taken nine months ago. (C) Closer view (arrows: violaceous lesions suspicious of Kaposi's sarcoma between psoriatic lesions).
Fig. 3(A) Extensive vascular proliferation with multiple dilated vascular spaces of back-to-back configuration and spindle shaped cells in the dermis (H&E, ×100). (B) Positive for human papillomavirus-8 (HHV-8 immunohistochemistry stain, ×100).
Summary of reported cases of KS in psoriasis patients
| Author | No. | Age (yr)/sex | Type of KS | Duration of psoriasis (yr) | Comorbidities | Suspected cause of KS (duration of treatment) |
|---|---|---|---|---|---|---|
| Philipp et al. | 1 | 60/M | Iatrogenic | 40 | - | Fumaric acid esters (25 months) |
| Tebbe et al. | 2 | 59/M | Iatrogenic | 46 | Chronic obstructive lung disease | Prednisolone treatment (5 months) |
| Dervis and Demirkesen | 3 | 54/F | Classic | 29 | Hypertension | Cilazapril (ACEi) (9 months) |
| Sorce and Bongiorno | 4 | 74/F | Classic | 15 | Hypertension, vitiligo, monoclonal gammopathy of undetermined significance | Immune dysregulation underlying chronic inflammatory disorders |
| Verdelli et al. | 5 | 78/F | Iatrogenic | - | - | Tocilizumab (13 months) |
| Ursini et al. | 6 | 49/M | Iatrogenic | 9 | Diabetes mellitus | Infliximab (15 months) |
| Selvi et al. | 7 | 75/F | Iatrogenic | 30 | - | Intra-articular steroid injection for psoriatic arthritis |
| Fargnoli et al. | 8 | 56/M | Classic | 20 | Down syndrome, | Down syndrome-related compromised immune surveillance |
| Häring et al. | 9 | 46/M | Classic | 10 | - | UV light therapy |
| Our case | 71/M | Classic | 10 | Hypertension | Unknown, maybe due to immune dysregulation under chronic inflammatory dermatosis, psoriasis |
KS: Kaposi's sarcoma, M: male, F: female, -: not mentioned, ACEi: angiotensin-converting enzyme inhibitor, UV: ultraviolet.